hahn: there are many. we are getting hundreds of applications and prioritizing those where we think the science best. we look at every application. yes, i do think that's the case. i am limited by confidential commercial information and i cannot speak to anything not in public domain but i do think that's the case you're describing. academics,mendous drug innovators, manufacturers, who are looking at a wide range therapeutics. although we have seen evidence that our mitigation efforts are have to keep pushing forward aggressively on this because we need to make sure have all the available resources as we move into the summer and the fall. pres. obama: since we're in the middle of a pandemic, if some of approval,s get f.d.a. will traditional f.d.a. rules for directions consumer advertising be relaxed way?y dr. hahn: we are going to look at all of our authorities and be as flexible as possible. this is another point of risk versus benefit. usingemergency situation emergency use authority, our job is to asses

i am joined by stephen hahn, commissioner of the fda. he oversees efforts on public health, drug approval and medical testing. so much forank you being with us today. >> thank you for having me. >> we have heard a lot from anders about this interview the top question for almost will a reliable antibody test be available for use across the nation? test is a test that detects a person's natural immunity after having had the virus. afteris a timing issue which the test would work. the reason i bring it up is it has its role but it is based on the timing of when the antibody would develop. the fda's role is to evaluate thetest and determine reliability and read -- and reproducibility of the test. as part of our flexibility in march we permitted laboratories to develop test and come to market and use them as long as they validated the test. 84 companies and labs have told us they are doing that. we expect more to come to the oversightere fda has of the testing characteristics and has the stamp of approval with fda so we can expect more compan

stephen hahn. dr. hahn, welcome to "meet the press." happy easter. i want to start simply with this. the president would like to lift social distancing guidelines on may 1st. is that timeline at all realistic in the next three weeks? >> well, thank you, chuck, for having me on the show. really do appreciate it. i think obviously everybody wants to get back to work. i have been hearing that from friends and colleagues around the country. certainly, there are urgent economic reasons for that. however, i think the task force, the president, the vice president, all the doctors on the task force, are really looking at this from balanced approach. the primary issue here is the safety and the welfare of the american people. that has to come first. that has to be our first consideration. and i think we have seen the mitigation efforts working. we have really good signs of that now which i think is such a great -- speaks to the resiliency of the american people, but that has to be balanced with all the other issues that have to be taken into account as we mov

. >> my guests this t(morning, fd commissioner steve hahn, dr. david fvidko nabarro, mark mcclellan, and vin gupta from the university of washington. also,Ñ@cernie bows out. >> while this campaign is coming toe1 an end, our movement is no. >> can joe biden do what hillary clinton could not, win over sanders supporters? joining me for insight and analysis are nbcxdó[st welker, author and historian jon meach meacham, yamiche t(alcindor, an lonny chen, fellow at the huver institution. welcome to sunday and a special edition of "meet the press." >> announcer: from nbc news in washington, the longest running show in telephovision historyyÑ this is a special edition of "meet the press" with chu' tor.ip &h(lc% >> good sunday morning and a happy easter and a happy passover. it's hard to talk about good news when more than 2,000 people are dying on a daily basis in this country, butq this past week, we did see some reasons for e1optimism, verye1 cautious optimism. as of this morning, there haveo been more than half a millionñr confirmed cases of cov

stephen hahn and others represent a level of commitment to dedication and it has been inspiring. thank you for your gracious word. it was reported to us that more than 746,000 americans had tested positive for the coronavirus. american have00 fully recovered, but more than 41,000 americans have lost their lives to the coronavirus. we always want to express our deepest sympathies. today, we have seen encouraging progress asout our a nation.

stephen hahn, a highly respected man from a great institution left that job to come here. the job he's doing is incredible. we are working with scott, his predecessor. the speed of development for anti-viral and immune therapies is at a level thob even thought was possible. we are getting very good results. if we could find the therapies that would solve the problem. if somebody has a problem we can get it taken care of so it's not so devastating. with that i will have vice president pence to come up. it's sunday evening. and this man has thought stopped. he's working -- we all are in all fairness. but he's been working with his task force round the clock for months, and i want to thank mike. thank you, mike.

steven hahn, the member of the white house coronavirus task force joining us live. dr. hahn great to see you this morning thanks very much for joining us. >> hi, maria thank you for having me it's great to be here. maria: so its been about two weeks now since the president called on the fda to cut red tape. we know we are entering a very dangerous stretch, the next two week period which the president has called horrific. give us a status check. how do you see things today? >> so first of all, i just want to reiterate what the president and the task force members said yesterday that mitigation appears to be working, we're beginning to see signs of that. it's really important for everyone to continue to follow that and i think the american people have done a great job. so, with respect to the issue of red tape, this is always a balance but what we're doing is trying to remove as much unnecessary regulation as possible to speed medical products to the american people. at the same time, the american people depend upon us, to actually ensure that medical products are safe an

hahn will provide updates. we continue to gain ground in the war against the unseen enemy and i see light at the end of the tunnel. i actually see a lot of late at the end of the tunnel and we're starting the process. we're starting a very, very powerful, important process. you see that people are getting very anxious. they want to get going. they want to get back to their jobs. they want to make money. they want to take care of their families. so the light is getting brighter and brighter every day and with that, if i could, i'll ask dr. birx to come up and then dr. hahn. thank you very much. dr. birx: thank you, mr. president. so, looking at all of the information across the united states, we do see improvement across all the large metros. i know you know that we have been talking about the new york metro area, new york city, rhode island, connecticut, long island. and really we do start to see improvement there and we see improvement even now in rhode island and connecticut. the detroit metro is doing quite

stephen hahn. great to have you with us tonight, doctor. >> thank you, shannon, i really appreciate being on your show. my best to the viewers. >> shannon: thank you so much. we have a lot of questions for them and just in general, but let's start with a vaccine. what can you tell us about a timeline from any updates? what realistic hope is for american folks out there and also come is that the point which we go back to "normal?" >> so vaccines will be very important because if a vaccine can be developed that gives a significant amount of immunity, we can vaccinate millions of americans very similar to the flu and protect them from reinfection with the covid-19 virus. so it is a critical part of the public health response to this illness. so we have authorized two clinical trials for vaccines. one is already going and has been for the last month. and that is really good news because this virus was only really identified back in january. so really lightning speed for getting this forward. and the pr

stephen hahn. dr. hahn, it's great to see you again. thanks so much for being here. >> maria, thank you for having me. it's great to be back on your show. maria: so is it fair to say that we've gotten beyond the testing issues? are you confident that there will be enough testing for anyone who needs a test to actually get back and reopen the economy? is that critical? >> so testing is a really important part of this phased approach to opening up the u.s. economy. and just think about where we've come in the last six to eight weeks from tens of thousands of tests to now having done over 5 and-a-half million tests or close to it. so i am confident that we have a plan for ramping that up. you probably know and heard someone say from fda that we have over 390 test developer whose are working with us to increase capacity further and get more tests out there. so we're working very closely with the states to actually get that done. maria: dr. hahn, i want to ask you about a vaccine and about therapeutics. tell us what you see in terms of the m

stephen hahn saying it's too early to determine if it might work for other patients. >> what fda is going to require his data from randomized clinical trials to actually make a definitive decision around safety and efficacy. >> the white house also pushing back today on reports the cdc director dr. robert redfield warned that coronavirus could come back this fall even worse than now. in an interview with "the washington post," he is quoted as saying there's a possibility the assault of the virus on our nation next winter will actually be even more difficult than the one we just went through. white house officials insist redfield was talking about the potential for a coronavirus resurgence at the same time seasonal flu kicks in and the burden that double whammy could put on the health care system. in a new development, the former deputy hhs secretary for preparation and response is filing a whistle-blower complaint tonight claiming he was transferred to a lesser position at the nih after disagreeing with the white house over which drugs and treatment to spend billions of dollars on. in the

hahn: we have over 30 clinical trials. they're in outpatient setting, inpatient setting and importantly, in what we call the post-exposure prophylaxis meaning if you're a front-line provider and have been exposed to the virus, take the drug to see if you can prevent the development of the illness related to the virus and all those trials are in early tages. pres. trump: i want to say in addition to the tests that we already have and we have tested more people than anybody anywhere in the world by far, by very far. reporter: hydroxychloroquine, i wonder if you're concerned, the v.a. study showed that more people died that used the drug than didn't and i'm wondering if governor cuomo brought you back any results? pres. trump: we didn't discuss it and i don't know of the report. there have been some very good reports and perhaps this one's not a good report but we'll be looking at it and have a comment on it. eporter: a panel of experts at the n.i.h. is recommending against the use of hydroxychloroquine in combination with z-

congressman gaetz and hahn next. these folks, they don't have time to go to the post office they have businesses to grow customers to care for lives to get home to they use stamps.com print discounted postage for any letter any package any time right from your computer all the amazing services of the post office only cheaper get our special tv offer a 4-week trial plus postage and a digital scale go to stamps.com/tv and never go to the post office again! ♪ >> one of the most awful things i have ever seen in my life. the extent to which they'll go to, it's all about one supreme court seat. they will kill people to stay in power, literally. >> laura: joining me now is florida congressman matt gaetz and chris hahn, the host of the that was james carville here that was a lot of fearmongering there. is this a preview of how we are going to politicize this pandemic right up until election day? >> in the most insincere of ways because president trump had a historic turnout on election day. there may be some voices trying

hahn to speak and he's been doing yeoman's work at the fda. thank you very much. doctor? >> thank you. thank you. tlaung, mr. president. i'm going to speak about hydroxychloroquine and the efforts around that. just to preface, i'd like to echo what the president said about the american people and the resiliency and the just terrific work, mitigation is such an important part of our fight against the covid-19 virus. last week, as the president said, we issued an emergency use authorization to allow the donated hydroxychloroquine to come into the country and enter the general circulation. we are prioritizing this drug to come in for clinical trials, also to general use for physicians because as you know, physicians, based upon their interaction with the patients, their assessment of the risks and benefits, can write a prescription for hydroxychloroquine if they think it's appropriate for the patient. being a physician, we do this all the time. and that assessment needs to be done between a patient and a doctor. and then the third portion is, we wanted to make sure that thes

congressman matt gaetz and chris hahn are here to debate and is biometric tracking relieving answer to containing and defeating the coronavirus? how we can reopen our government, our country. what does it mean for your privacy? victor davis hanson will explain it all. plus, we're going to show you part two, sean just referenced it of my exclusive interview with attorney general bill barr. he reveals what he really thinks about trump's firing of that intel inspector general and about john durham's investigation. but first, this is america and shut down day 24. some important developments. and some emails that i must share with you. as new york remains the covid cauldron of america, 799 more folks in new york died yesterday, bringing the state total to a staggering 7,067. now, that's 43% of all american fatalities, to get your mind wrapped around that. the public hospitals especially remain battlegrounds, but the state overall continues to make some progress against the virus. >> we had 200 net increase in hospitalizations, which you can see is the lowest number we've had this nightmare

hahn making a few remarks, what are you hearing whether health experts whether it is commissioner hahn or dr. birx feel pressure to go along with the president over science? toluse: president trump said he his brain and said he has the information he needs to direct the federal health response to this pandemic. the president wants to play a central rule talking about drugs that have been not vetted and it is laughab like using light inside people's bodies or disinfectant to try to get rid of a virus that very many scientific experts around the world are tryinging to figure out ways to get rid of the virus and the president trump who has no medical expertise may convince his supporters but does not actually work when it comes to getf rid o this virus. all of these experts are trying to tip toed aro the president and explain his comments and ways to work with him, work with his unique personality but it has been difficult. and dr. bright being pushed out and dr. bx and dr. fauci trying to figure out ways to stay on his good side and listen to him when they bring difficult decisions. and

hahn, if i may. in your remarks that you made just a few moments ago in regards to reopening the u.s. economy you said i want it to be safe. that's the sentiment obviously. tens of millions of americans. it seems at odds with the tweet that you had friday about liberating those three particular states, virginia, minnesota, and michigan because none of those states have met the requirements that the vice president and others on the task force talked about in terms of reopening the economy. do you see those two -- president trump: if you take michigan. there were things in the michigan i don't think were necessarily appropriate. everyone knows that. i think the governor of michigan probably knows that. i will bet she wishes she didn't put some of them in. you can't buy paint or seeds. where did this stuff come from? we have to be safe. we don't want to close anything. we won't be closing. but we'll be doing it beautifully, systematically. we are working well with the governors. a couple of them no matt

hahn, who i have tremendous respect for, dr. hahn used to run the m.d. anderson cancer center which is a world renowned cancer center. and he said on the town hall, and i say this with great respect, but he said, these are conversations that are happening between patients and doctors all the time. no, they're not. i don't think there's many patients who are going into their doctors saying, hey, i think it's a good idea to inject disinfectant into my body, what do you think, doctor. no. we have a certain fundamental level of knowledge that we should pivot to, not run away from. that part of it concerned me the most. >> tom, your colleagues at "the new york times" reported today that the president rarely attends these coronavirus task force meetings that take place in the afternoon before the white house press conferences, the briefings, as they're called. how concerning is that when more than 50,000 americans have now lost their lives in a matter of only a few weeks? >> wolf, it's shocking. and you really have to ask republicans and republican lawmakers,

hahn: we provide flexibility. we have told manufacturers that in order to market in the u .s., they have to validate their test, tell us they have validated the test, and in the packet insert, they have to tell people that the tests were not authorized by the fda. more are in the pipeline. inse tests that have come without any information to us but have self validated, as i mentioned a couple of days ago, we are working with the national cancer institute as well as cdc to perform our own validation of the tests sent to us. we will provide as much information as we possibly can and there is transparency on a website about those tests and also the tests we have authorized. vice pres. pence: thank you, mr. president. from early in this effort, president trump has called for a whole of government response to the coronavirus epidemic in america. by that, the president made clear when he asked me to lead the white house coronavirus task force, not merely a whole of the federal government a full partnership with state an

fda commissioner steve hahn joins me now. commissioner, thanks so much for being here. i want to get to these drugs with you in a second but i want to ask you a big picture question first of all which is when you look at these models and you see the number dropping now into the 60,000 range by august, why do you think that is? why is that number getting lower and lower. of course very glad to see it. it is still way too many but it's much better than had been expected. >> martha, thank you for having me on the show tonight and first of all is a cancer doctor who practiced medicine just a few minutes -- a few months before i took this job, my heart goes out to those who have lost loved ones from this terrible virus. so the big picture here i think is, as we've heard from the coronavirus task force is that mitigation is working. i think that's our number one offense and defense against this virus. it's really gratifying to see some encouraging results from mitigation. i think the other thing that we will dig into is more and more data and information comes to us is what a

i'm raja pra hahn wiprad hahn i. nearly 4-infections were reported on thursday, bringing the trotal to more than 5,300. and tokyo saw record increase for the second day in a row. the set toal does ntotal does n cases from the cruise ship that was docked earlier this year. 1700 people have died across the country including 11 from the ship. more than 1500 people have now tested positive in tokyo. officials confirmed 181 new cases on thursday in the capital which is home to around 14 million people. the increase comes two days after the government declared a state of emergency for some parts of the country. officials are calling on residents to stay home as much as possible and practice social distancingng. a number of museums, theaters and parks have shut voluntarily. the operator of tokyo disneylald anand tokyo disney sea has decid to keep those facilities closed until at least mid-may. now, japan's government and the tokyo metropolitan government are in talks to decide which businesses i will be asked to close durin

hahn: thank you, mr. president. i just want to add, dr. birx said just a few short months ago, i was one of those doctors on the front lines and i know how terrific they are working and how well they are doing for the american people and a shout out to them for just the wonderful work that they do every day. so, president trump asked the fda to remove all unnecessary barriers that were in place to help with the development of both diagnostics and therapeutics, and we have done that. i'm here to give you an update on the efforts around tests, which as you know antibody tests, which detect in the blood natural immunity that someone might develop in response to an infection, in this case, covid-19. these aren't diagnostic tests. they are tests that actually detect the antibodies, an indication that one has had the infection and has responded. i think it's important for everyone to understand that the timing of the response of the antibody to the infection isn't completely known, but we know that it takes some time to actually develop. there a

hahn? dr. hahn, speaking of 140 different developers, more than 90 manufacturers. how many of tests actually work? >> as i mentioned 90 come forward marketing in the u.s., they are required by us to have self-validation and they're required to label that appropriately in the package insert. they also said what we're doing we're working with folks around the country but here at home, u.s. government with the nci and cdc to validate some of those tests that have come forward to us. we're actually doing independent validation. reporter: what have you found so far? >> we don't have the results yet. i expect to have more results this week but we'll be transparent about the results because i think it is very important. your question is superb if someone wants to use a test that's come to market really important to read the information that's in the package insert but often in some of those cases it is also important for the independent labs to do the validation also. you may have seen reports in the press of labs around the country that have done that we have reached out

an investigation of product for use with those who are seriously ill from covid-19 hahn says the fda is now working to make reliable antibody testing widely available by continuing to provide the opportunity for interested developers to request fda authorization. for today's health minute. i'm mandy gaither. >>well here's a quick live look outside a camera shot here at the bay bridge toll plaza where we're tracking your ride on this friday morning and as usual now it is morning and as usual now it is a pretty easy go. we'll wow! i'm original. one of a kind. you feel me? love ya'. oop! you look cute. better than you! wherever drama pops off pop my 100% all-white-meat classic or spicy popcorn chicken combo for just $5.99. is so irresistible, you'll wanna eat them anywhere, so don't resist! pop 'em outside, or on the go, or on the way home! pop my 100% all-white-meat classic or spicy popcorn chicken combo for just $5.99. 30's. the time big story this morning, a billion coronavirus relief bill is now waiting for president trump's signature. but there are some concerns about the part of t

hahn: thank you, mr. president. i appreciate the opportunity to tell you what is happening at the fda. we have a team of more than 18,000 employees, including 10,000 scientists, doctors, pharmacists and nurses. they have been working around the clock. many of the medical products being used for the outbreak are regulated by fda. the staff have been hard at work authorizing test and other medical products. as part of these efforts to support diagnostic test developments during this global pandemic, the president has asked us under his leadership to actually cut down as many barriers as we possibly could to get medical products into the medical community. we have done that, recognizing the urgency of the situation. i do want to emphasize with the president said that we are very much paying attention to safety. and with respect to tests, validity and reliability of those tests. it is important to understand how far we have come in just a few short months. the academic community, which i come from, the private sector, t

hahn as well. i don't know how they continue to do the job sometimes because they just have to spend as much time spinning around this stuff as they do actually talking about the science. >> that's the part of it, look, she looked like she was dying inside when he was saying it. and if she wasn't, she should have been. it does make you wonder about whether she should have said something right then and there. because to let that hang out there and have people wonder about injecting disinfectants even if they were is dangerous. and if people are having those conversations with their doctors, it is because they heard the president say it yesterday. and it just can't, can't happen. i don't know what else to say about it. >> it doesn't work. d it doesn't need to be studied. let's study this, no, we don't need to study it, we already have the answer. to do a study means you would knowingly inject something that could kill people into one group of people and not into another group of people and then prove

hahn? >> dr. hahn, you're speaking of 140 different manufacturers. how many of these tests actually work? >> so as i mentioned the 90 that have come forward and said they're marketing in the u.s., they have required by us to have self-validation and they're acquired to label that appropriately in their packaging insert. what we're doing is working with folks around the country, but here at home, a u.s. government with the nci and cdc to validate some of those tests that have come forward. so we're actually doing independent validation. >> what have you done so far? >> so we don't have those results yet. i expect to have more results this week. but we will be transparent about the results because we think it's very important. and your question is superb in that if someone wants to use a test that's come to market, really, it's important to read the information that's in the package insert, but often in some of those cases, it's often important for some of the independent labs to do the validation also. you may have seen reports in the labs around the

hahn: there is a chance and and dr. birxauci talked about this. the key is the surveillance being put in place with the cdc. i think that will be a great help in terms of reducing that risk. thank you. pres. trump: i think they have the rest of that clip i thought , it was a good clip. i think it is a tribute to new york about a tribute to the federal government, and i thought it was nice. i think they have that now. they can try it. go ahead. [video clip] >> did we save everyone? no. but have we lost anyone because we did not have a bed or a ventilator or we did not have health care staff? no. the people we lost our the people we cannot save. not for lack of trying and not for lack of doing everything that we could do as a society, not only as a government and health care system. pres. trump: ok. reporter: you shared with us something else you saw on tv today. i have a question about something you said thursday. you were angry because information about the virus should have been told to us earlier and sooner. people knew it was coming and people

hahn. here is a question. there is an epidemiologist at the university of birmingham, a covid-19 survivor and his question is this, why would the virus suddenly be different and why would people are susceptible be any different on june the 1st or july the 1st. this is relating to reopening the economy. can you explain or give an answer to that question? >> i don't think we have an everyday that one is more susceptible or less. i think we can say the med gas station efforts have really helped with respect to this and what we have seen is the number of cases have gone down. if we follow the criteria for opening we are able to institute phase one and appropriate measures in place to reduce any chance of flare up of the cases. >> rebounding and if you reopen too soon without the type of mitigation efforts that we had still in place. >> yes, there is a chance and dr. fauci and dr. birx talked about it. the key is the surveillance that's being put in place with the cdc. i think it will be a great task to reduce that

stephen hahn now to tell us more. good morning. americans are sitting at home now and they're wondering two things -- when can i get back to work, and can i do it safely. this at-home test, tell us about it. where does it fit into the bigger puzzle of testing which seems so important to doing those two things -- return to normalcy, returning to the economy, working as usual. >> good morning. thank you for having me. so this new test is an at-home collection test for diagnostic. that is a test that would diagnose the presence of the covid-19 virus. this is a test where it's going to focus lab corps, the company that's developed this, is going to focus first on frontline health care workers and first responders. those with symptoms can go on line and fill out a questionnaire. the questionnaire will be reviewed by a health care professional, a licensed physician, and if appropriate and consistent with the cdc guidelines, a package will be sent overnight with a swab and a tube. it's very easy and safe to perform. our data show that it'

stephen hahn joins us now. good morning, dr. hahn. i want to start with the latest models, which projects that the u.s. peak in terms of daily deaths would likely be today. hitting the top of curve and then starting to come down. have we peaked and does this mean the worst may have passed? >> martha, thank you for having me on the show. so, the models do show that we are very close to the peak and so i think that information is accurate. this has been a very fast-moving outbreak and so we really have to take this day by day. we have some of the best experts in the world, dr. fauci and dr. birx on this. i think that information is accurate, but again, we have to take day by day. as the data comes in. this has to be a data-driven approach. >> of course the president initially set today as a target date for reopening the country. he backed off of that. but there are new warning signs about opening the country by may 1st. "the new york times" obtained new federal projections showing a spike in infections if restrictions are lifted. predic

lincoln's suggestion to governor hahn is remarkable in several ways. most importantly it's the first time that a sitting president advocates for the right to vote for black men. clearly, the arguments put forward by the delegation by louisiana had begun to influence the way lincoln is going to think about this issue. it's also worth noting that lincoln actually advocated for a broader expansion of suffrage than even the two black men from louisiana had asked for. they wanted the right to vote for elite black men, taxpayers and lincoln wants the right to vote for people who are very intelligent meaning educated or who bear arms for the union regardless of their financial status. a month after this meeting, lincoln met with another delegation, six black men from north carolina came to lincoln asking for the right to vote in their state. the leader of this group was a man named abraham galloway and it was in 1837 in north carolina and she was a how and when he got to philadelphia blood was coming out of his pores because of the turpentine. early in the ci

joining me now is caroline german director from global citizen organizer of the one world together at hahn carolyn wrangling big stars can be a tricky business how complicated was it to get stars like the rolling stones elton john or billy eilish to sign up to this cause. well it was actually pretty straightforward because a lot of these artists are very eager to do that that crisis as well and we've worked with many of them. to come and i said yes immediately and of course we had a lot of help from a guy who was it got the whole many are. right we'll get to the money question in a moment but what about the viewership thing well there's a captive audience at the moment how many people have seen it. was the collating all of the final numbers because human will be a very large number in the millions because we know that people in over 170 countries that watched it and actually can still watch it on all of the major streaming down. the constant was billed as a love letter to front line health workers carolyn so far more than $100000000.00 has been raised as i hear how will this money be used.

hahn. you, mr. president. shery: you have been listening to president trump briefing the press about his immigration cause in effect for 60 days. he said he had talked to governors including andrew cuomo in new york. let's discuss the latest developments with our government congressional reporter emily wilkins on the line from washington. line from washington. we were expecting some sort of action on the immigration front. tell us about what this means and what sort of authority the president has to carry out this immigration halt. trumpit was announced, will be doing a delay in processing green cards. this was something we expected last night. that began to be reported. it is something other republicans have pushed for including jeff sessions, saying it will improve the health of america to do so. it should be pointed out processing of green cards as well as other immigration request has slowed down because of the virus, because of changes in staff and everyone trying to adjust to the new reality of having to

. >> peter jin hahn says the blood was from a blood big in the stamford area with someone who had covid-19 and had the same blood type as the critically ill patient . doctors will see if this is spiritual tremendous helpful, even though more studies are needed. the hope is that convalescent plasma will act as a stun gun. >> average in the various makes more virus kidss, it ramps up and causes more virus instruction. if you shut down the virus making more kids, you can make sure i'm making those organs are focused on so they can be healed. that is what happens with the sickest patients. the less sick patients, this will probably prevent the organs from getting damaged in the first place. >> jin hahn says more donors are needed that have recovered from the covid-19 and have been recovered for at least 26 days. he says he believes his vision is among the first in the area. check ucf researchers have come up with community partners to test people in seven cisco's mission district. the free covid testing and to better understand how the virus affects the ltinex community and others. we have

we will hear from doctor stephen hahn in minutes. white house correspondent kevin cork has the latest on the trillion dollar rescue plan. >> we expect him to sign the latest coronavirus relief bill with the $484 billion price tag. it will fund small businesses and hospitals and push the total response to $3 trillion but not a moment too soon as the number of americans out of work and looking for help continues to skyrocket. the latest numbers show 4.4 million claims bringing the total over $26 million. for context that is more than all the jobs added to the economy in the past we 10 years since the great recession but despite a tough numbers trust me, things will get better soon. >> our economy will start to pick up very substantially as soon as the states get open and that is happening as we speak and it is very exciting and people are just thrilled to see it because our country has to get back to work. >> back to work is what a number of people in a growing list of states will be doing fairly soon, you can add colorado to the list

stephen hahn. >> you can use saliva rather than a swab in the nose. it's more comfortable for the patient and can be repeated several times and it's safer for the healthcare provider in terms of collection. this is not an at-home test. it has to be performed with a provider. but it provides great advantages moving forward. lou: joining us is dr. ian lipkin, the director for infection and immunity at columbia university. he's researching the use of blood plasma drawn from patients who have successfully recovered from the virus. the doctor tested positive for the virus in the past month. it's great to the have you with us. i want to get to the news of this -- great to have a new test that is as simple as this one sounds. a spit test, if you will, that is not intrusive, is speedy, and every bit as accurate as other tests out there. >> it will be more convenient and less instraysive. i don't know if it's as sensitive as the nasofir nays nl swabs. it's not revolutionary but we'll have to see how sit performs. lou: that seems to be the case with just about

hahn. when validated, we're confident that the production will scale up to tens of millions of tests very quickly. we're leading the world now in testing, by far. and we're going to keep it that way. other countries are coming to us, and they are wanting to know about our tests and can they buy the tests and can they do whatever they have to do to get the tests, and we're going to make that -- very soon we will be in a position to make that possible because it is important for them to have it. and we're going to have an announcement on the world health organization sometime next week. as you know, we've given them approximately 500 million dollars a year, and we're going to be talking about that subject next week. we will have a lot to say about it. we'll hold it. every american should be proud of what our country has achieved in just a short period of time. the u.s. military has deployed thousands of personnel to build 23 temporary hospitals, with more than 16,000 beds. and we have the pot

hahn. we needed to separate out who has been exposed to him who hasn't, and who may be cured. right now we need it. i think in a couple of weeks. >> tucker: good. that is hopeful. dr. siegel, congratulations. >> it will change the game.ro speed to see you tomorrow. thanks. programming note before we go tonight, the governor of the state of new jersey phil murphy is coming on tomorrow night. hope you will join us then. have a great evening. sean hannity right now. >> sean: look forward to that tomorrow. welcome to "hannity." more positive statistics on this country's fight against covid-19 and more bold action from this president, more against the china centric also secretary of state mike pompeo, fascinating information they have released from the state the payment. we'll ask him about it. with 203 days till election day and you, we, the people, you are theay ultimate jury, quid pro qo joe, the ever confused one, finally got the endorsements he's been anxiously waiting for in the middle of a pandemic and the national

it went to her lab partner, otto hahn, who was a chemist. what i read, otto hahn was a very nice man and a very good chemist and maybe even deserved the nobel prize for something else but he sure didn't deserve it for nuclear fission because he didn't really understand nuclear fission. the men and they were men amenable committee just couldn't wrap their heads around the idea that it could have been a woman responsible for this enormous breakthrough. they fell back into what we were talking about, confirmation bias, must be the woman behind the man, the man who does it and it is the one behind the man so they gave the nobel prize to the man. many years later the proceedings of that nobel committee were released. a certain number of years bonobo proceedings are released and a group of physicists looked at that and called it the most agreed to send indefensible oversight ever. for egregious and defensible oversights there's a lot of competition. but what kelly was referring to is many physicists since have tried to make it up to lease meitner.

♪go your own way save at anoro.com >> steven hahn, dr. hahn, incredible at fda. been done at record time. never been anything like it. we want everything to be safe. we like to see -- elizabeth: that was president trump earlier today launching a major new push. its nickname is operation warp speed to get hhs and the fda ramped up to get a vaccine underway more rapidly to stop the coronavirus outbreak. let's bring in our next guest. he is dr. bob hida, chair of medicine at saint joseph's university. >> it is a great push, liz. as you know the vaccine most promising right now is the one from oxford university because they have bypassed phase one since they were working with the coronavirus, not krona 19. they will having seen by early fall which is exciting. some are beginning to end phase one and go into phase two. so i'm really excited about that. elizabeth: there is stop of hope stopping covid-19 with gilead's drug remdesivir. it may be be effective just five-day es dog regimen. it is now getting fast-tracked. dr. anthony fauci is positive about this drug remdes

stephen hahn. >> welcome to "watters world." if you can, and please do it in the most rudimentary way, explain where we are with this anti-malaria drug that everyone's talking about. >> thanks, jesse. thanks for having me on your show. so this drug, there's two drugs, one's called high docks owe chloroquine -- hydroxychloroquine and one is called chloroquine. both of these drugs are available for use around the world. hydroxychloroquine is approved by fda for other diseases, not covid-19. jesse: right. >> now, the drug is available for prescription by a physician and putting on my doctor hat, that would mean if a patient or a doctor thinks that hydroxychloroquine might benefit them, that's an individual patient/doctor decision. but we are also performing clinical trials because what we want is the necessary information to make a decision at the fda about whether it's safe and effective for covid-19. there are some preliminary data that we have from around the world that suggests it might have a benefit. but those data aren't suf